GMS Ventures & Investments

CIK 00018045981 companyGRAND CAYMAN, E9

SEC Profile

Transactions

Companies

Filings

CIK

0001804598

Recent Transactions

19 trades

Award
Outlook Therapeutics, Inc.$OTLK
Common Stock
2025-05-27$1.40/sh+4,285,714→ 13,552,359 total
Award
Outlook Therapeutics, Inc.$OTLK
Warrants (right to buy)
2025-05-27+8,571,428→ 8,571,428 total
Award
Outlook Therapeutics, Inc.$OTLK
Warrants (right to buy)
2025-01-17+3,458,571→ 3,458,571 total
Exercise/Conversion
Outlook Therapeutics, Inc.$OTLK
Common Stock
2025-01-17$2.51/sh+3,458,571→ 9,266,645 total
Exercise/Conversion
Outlook Therapeutics, Inc.$OTLK
Warrants (right to buy)
2025-01-17−3,458,571→ 0 total
Award
Outlook Therapeutics, Inc.$OTLK
Warrants (right to buy)
2025-01-17+3,458,571→ 3,458,571 total
Disposition to Issuer
Outlook Therapeutics, Inc.$OTLK
Warrants (right to buy)
2025-01-17−3,458,571→ 0 total
Award
Outlook Therapeutics, Inc.$OTLK
Warrants (right to buy)
2025-01-17+3,458,571→ 3,458,571 total
Award
Outlook Therapeutics, Inc.$OTLK
Warrants (right to buy)
2024-03-18+3,458,571→ 3,458,571 total
Award
Outlook Therapeutics, Inc.$OTLK
Common Stock
2024-03-18+2,305,714→ 5,808,074 total
Award
Outlook Therapeutics, Inc.$OTLK
Common Stock
2022-12-28$0.88/sh+14,230,418→ 70,047,204 total
Other
Outlook Therapeutics, Inc.$OTLK
Common Stock
2022-04-21+27,982,529→ 55,816,786 total
Other
Outlook Therapeutics, Inc.$OTLK
Common Stock
2022-04-21+27,982,529→ 55,816,786 total
Other
Outlook Therapeutics, Inc.$OTLK
Common Stock
2022-02-01$1.25/sh+2,500,000→ 27,982,529 total
Purchase
Outlook Therapeutics, Inc.$OTLK
Common Stock
2021-11-29$1.25/sh+16,000,000→ 27,834,257 total
Award
Outlook Therapeutics, Inc.$OTLK
Common Stock
2021-02-10$1.00/sh+1,013,627→ 11,834,257 total
Purchase
Outlook Therapeutics, Inc.$OTLK
Common Stock
2021-02-02$1.00/sh+8,360,000→ 10,820,630 total
Award
Outlook Therapeutics, Inc.$OTLK
Warrants
2020-02-26$0.13/sh+1,230,315→ 1,230,315 total
Award
Outlook Therapeutics, Inc.$OTLK
Common Stock
2020-02-26$1.02/sh+2,460,630→ 2,460,630 total

Companies

Outlook Therapeutics, Inc.
Director, 10% Owner
$OTLK

Recent Filings

Address

190 ELGIN AVENUE GEORGE TOWN

GRAND CAYMAN, E9, KY1-9007

View on SEC.gov